An engineered serine protease inhibitor targeting furin prevents the activation of the measles virus fusion glycoprotein, drastically reducing infectious virus production and offering a potential novel antiviral approach.
No takes yet. Share an insight, caveat, or question.
May support furin inhibition as measles antiviral strategy; leaves open clinical translation and human efficacy.
Watanabe et al. (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: